For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our (Global Info Research) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at USD 10610 million in 2023 and is forecast to a readjusted size of USD 15580 million by 2030 with a CAGR of 5.6% during review period.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
The Global Info Research report includes an overview of the development of the Intravenous Immunoglobulin (IVIg) industry chain, the market status of Immunodeficiency (IVIg Liquid, IVIg Powder), Autoimmune Disease (IVIg Liquid, IVIg Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous Immunoglobulin (IVIg).
Regionally, the report analyzes the Intravenous Immunoglobulin (IVIg) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous Immunoglobulin (IVIg) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous Immunoglobulin (IVIg) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous Immunoglobulin (IVIg) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Bottle), revenue generated, and market share of different by Type (e.g., IVIg Liquid, IVIg Powder).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous Immunoglobulin (IVIg) market.
Regional Analysis: The report involves examining the Intravenous Immunoglobulin (IVIg) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous Immunoglobulin (IVIg) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous Immunoglobulin (IVIg):
Company Analysis: Report covers individual Intravenous Immunoglobulin (IVIg) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous Immunoglobulin (IVIg) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunodeficiency, Autoimmune Disease).
Technology Analysis: Report covers specific technologies relevant to Intravenous Immunoglobulin (IVIg). It assesses the current state, advancements, and potential future developments in Intravenous Immunoglobulin (IVIg) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous Immunoglobulin (IVIg) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous Immunoglobulin (IVIg) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- IVIg Liquid
- IVIg Powder
Market segment by Application
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
Major players covered
- Baxter
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales, revenue and global market share of Intravenous Immunoglobulin (IVIg) from 2019 to 2024.
Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Immunoglobulin (IVIg).
Chapter 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion.